Gene Biotherapeutics, Inc. (7)

Browse by Contract Category

Contracts

Asset Purchase Agreement dated July 15, 2018 between Activation Therapeutics, Inc. and Olaregen Therapeutix, Inc. for the sale of Excellagen (Filed With SEC on April 23, 2021)
Description of Securities of the registrant (Filed With SEC on April 23, 2021)
Distribution and License Agreement dated April 10, 2020 between Angionetics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd (Filed With SEC on May 28, 2020)
Preferred Stock Purchase Agreement dated May 22, 2020 for the purchase of Series B Convertible Preferred Stock (Filed With SEC on May 28, 2020)
Reaffirmation and Ratification Agreement dated April 10, 2020 between Gene Biotherapeutics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd (Filed With SEC on May 28, 2020)
Amendment No. 1 to Distribution and License Agreement dated April 14, 2020 between Angionetics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd (Filed With SEC on May 28, 2020)
License and Patent Assignment Agreement dated April 10, 2020 between Activation Therapeutics, Inc. and Shanxi Taxus Pharmaceuticals Co., Ltd (Filed With SEC on May 28, 2020)